LeonaBio, Inc.
Data quality: 83%
LONA
Nasdaq
Manufacturing
Chemicals
$9.79
▲
$0.21
(2.17%)
Mkt Cap: 91.94 M
Price
$9.79
Mkt Cap
91.94 M
Day Range
$9.42 — $10.04
52-Week Range
$2.20 — $14.21
Volume
20,954
Open $9.79
50D / 200D Avg
$6.73
45.42% above
50D / 200D Avg
$4.99
96.28% above
Quick Summary
Key Takeaways
Negative free cash flow of -45.76 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-359.39%
Below sector avg (-53.41%)
ROIC-270.16%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio9.70
Interest CoverageN/A
Valuation
PE (TTM)
-0.87
Above sector avg (-1.48)
P/B Ratio3.43
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.9 | -1.5 |
| P/B | 3.4 | 1.6 |
| ROE % | -359.4 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -105.61 M |
| ROE | -359.39% | ROA | -322.09% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -45.76 M |
| ROIC | -270.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 9.70 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 24.24 M | Tangible Book Value | 26.79 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.87 | Forward P/E | N/A |
| P/B Ratio | 3.43 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -49.77% | ||
| Market Cap | 91.94 M | Enterprise Value | 71.07 M |
| Per Share | |||
| EPS (Diluted TTM) | -24.70 | Revenue / Share | N/A |
| FCF / Share | -4.87 | OCF / Share | -4.87 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 43.33% |
| SBC-Adj. FCF | -53.34 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -105.61 M | -96.94 M | -117.67 M | -95.64 M | -54.85 M |
| EPS (Diluted) | -24.70 | -2.52 | -3.09 | -2.53 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -102.27 M | -100.90 M | -125.47 M | -104.02 M | -64.02 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 17.50 M | 70.68 M | 93.79 M | 61.46 M | 42.79 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | 3,000.0 |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 92.15 M | 58.78 M | 160.25 M | 258.15 M | 332.01 M |
| Total Liabilities | 64.36 M | 13.94 M | 30.06 M | 23.02 M | 10.92 M |
| Shareholders' Equity | 27.79 M | 44.84 M | 130.19 M | 235.14 M | 321.08 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 69.28 M | 48.44 M | 90.58 M | 95.97 M | 110.54 M |
| Current Assets | 89.46 M | 54.84 M | 154.73 M | 207.53 M | 260.80 M |
| Current Liabilities | 47.50 M | 13.14 M | 28.84 M | 21.43 M | 9.29 M |
{"event":"ticker_viewed","properties":{"ticker":"LONA","listing_kind":"stock","pathname":"/stocks/lona","exchange":"Nasdaq","country":"US"}}